This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Brossart, P. Articles by Keilholz, U. Search for Related Content PubMed PubMed Citation Articles by Brossart, P. Articles by Keilholz, U.

A Polymerase Chain Reaction-based Semiquantitative Assessment of Malignant Melanoma Cells in Peripheral Blood¹

Department of Medicine V (Hematology/Oncology), University of Heidelberg, Hospitalstrasse 3, 69115 Heidelberg, Germany

Malignant melanoma cells can be detected with high sensitivity in peripheral blood of patients using reverse transcription-PCR. The detection of tyrosinase mRNA that is actively expressed only in melanocytes and melanoma cells indicates the presence of melanoma cells in peripheral blood. As shown previously, tyrosinase transcripts can be found in a variety of patients with metastatic malignant melanoma. For semiquantitative analysis of these cells in peripheral blood and evaluation of possible influence of immunotherapy on the amount of circulating cells, we describe an assay combining reverse transcription-PCR and Southern blotting. In this system, the amount of circulating tumor cells was determined by interpolating the amplified tyrosinase signal strength of patient samples to an equivalent tyrosinase signal of diluted SK-mel 28 cells. We found that the amount of circulating tumor cells correlates with the tumor burden. Furthermore, in patients with regression of melanoma metastases after immunotherapy, a decrease of the amount of tumor cells in the peripheral blood was observed. Quantitative estimates of residual disease may be an accurate and sensitive predictor for the clinical course.

¹ This work was supported in part by Deutsche Krebshilfe Grants M39/94KEl and W74/92KEl.

² To whom requests for reprints should be addressed.

Received 1/24/95. Accepted 7/12/95.

This article has been cited by other articles:

				K. K. Sra, M. Babb-Tarbox, S. Aboutalebi, P. Rady, G. L. Shipley, D. D. Dao, and S. K. Tyring Molecular Diagnosis of Cutaneous Diseases Arch Dermatol, February 1, 2005; 141(2): 225 - 241. [Abstract] [Full Text] [PDF]

				R. S. Faye, S. Aamdal, H. K. Hoifodt, E. Jacobsen, L. Holstad, E. Skovlund, and O. Fodstad Immunomagnetic Detection and Clinical Significance of Micrometastatic Tumor Cells in Malignant Melanoma Patients Clin. Cancer Res., June 15, 2004; 10(12): 4134 - 4139. [Abstract] [Full Text] [PDF]

				J. Szenajch, B. Jasinski, A. Synowiec, J. Kulik, M. Chomicka, J. Struzyna, Z. Nowecki, P. Rutkowski, W. Ruka, W. Kupsc, et al. Prognostic Value of Multiple Reverse Transcription-PCR Tyrosinase Testing for Circulating Neoplastic Cells in Malignant Melanoma Clin. Chem., September 1, 2003; 49(9): 1450 - 1457. [Abstract] [Full Text] [PDF]

				G. Palmieri, P. A. Ascierto, F. Perrone, S. M.R. Satriano, A. Ottaiano, A. Daponte, M. Napolitano, C. Caraco, N. Mozzillo, M. T. Melucci, et al. Prognostic Value of Circulating Melanoma Cells Detected by Reverse Transcriptase-Polymerase Chain Reaction J. Clin. Oncol., March 1, 2003; 21(5): 767 - 773. [Abstract] [Full Text] [PDF]

				B. Mellado, M. del Carmen Vela, D. Colomer, L. Gutierrez, T. Castel, L. Quinto, M. Fontanillas, N. Reguart, J. M. Domingo-Domenech, C. Montagut, et al. Tyrosinase mRNA in Blood of Patients With Melanoma Treated With Adjuvant Interferon J. Clin. Oncol., October 1, 2002; 20(19): 4032 - 4039. [Abstract] [Full Text] [PDF]

				A. Nencioni, F. Grunebach, A. Zobywlaski, C. Denzlinger, W. Brugger, and P. Brossart Dendritic Cell Immunogenicity Is Regulated by Peroxisome Proliferator-Activated Receptor {gamma} J. Immunol., August 1, 2002; 169(3): 1228 - 1235. [Abstract] [Full Text] [PDF]

				D. Santini, G. Tonini, B. Vincenzi, R. Murace, G. Ferranti, and A. Baldi Skin Lesions in Melanoma and Kaposi's Sarcoma: Case 1. Detection of Circulating Malignant Cells by RT-PCR in a Case of Cutaneous Melanoma in Complete Regression J. Clin. Oncol., March 1, 2002; 20(5): 1411 - 1412. [Full Text] [PDF]

				H. Tsao, U. Nadiminti, A. J. Sober, and M. Bigby A Meta-analysis of Reverse Transcriptase-Polymerase Chain Reaction for Tyrosinase mRNA as a Marker for Circulating Tumor Cells in Cutaneous Melanoma Arch Dermatol, March 1, 2001; 137(3): 325 - 330. [Abstract] [Full Text] [PDF]

				M. C. Kelley, R. K. Gupta, E. C. Hsueh, R. Yee, S. Stern, and D. L. Morton Tumor-Associated Antigen TA90 Immune Complex Assay Predicts Recurrence and Survival After Surgical Treatment of Stage I-III Melanoma J. Clin. Oncol., February 15, 2001; 19(4): 1176 - 1182. [Abstract] [Full Text] [PDF]

				M. Johansson, E. K. Pisa, V. Tormanen, K. Arstrand, and B. Kagedal Quantitative Analysis of Tyrosinase Transcripts in Blood Clin. Chem., July 1, 2000; 46(7): 921 - 927. [Abstract] [Full Text] [PDF]

				B. Vogelstein and K. W. Kinzler Digital PCR PNAS, August 3, 1999; 96(16): 9236 - 9241. [Abstract] [Full Text] [PDF]

				B. Mellado, L. Gutierrez, T. Castel, D. Colomer, M. Fontanillas, J. Castro, and J. Estape Prognostic Significance of the Detection of Circulating Malignant Cells by Reverse Transcriptase-Polymerase Chain Reaction in Long-Term Clinically Disease-free Melanoma Patients Clin. Cancer Res., July 1, 1999; 5(7): 1843 - 1848. [Abstract] [Full Text] [PDF]

				M. Muhlbauer, N. Langenbach, W. Stolz, R. Hein, M. Landthaler, R. Buettner, and A.-K. Bosserhoff Detection of Melanoma Cells in the Blood of Melanoma Patients by Melanoma-inhibitory Activity (MIA) Reverse Transcription-PCR Clin. Cancer Res., May 1, 1999; 5(5): 1099 - 1105. [Abstract] [Full Text] [PDF]

				G. Palmieri, M. Strazzullo, P. A. Ascierto, S. M.R. Satriano, A. Daponte, and G. Castello Polymerase Chain Reaction-Based Detection of Circulating Melanoma Cells as an Effective Marker of Tumor Progression J. Clin. Oncol., January 1, 1999; 17(1): 304 - 304. [Abstract] [Full Text] [PDF]

				P. Brossart, F. Grunebach, G. Stuhler, V. L. Reichardt, R. Mohle, L. Kanz, and W. Brugger Generation of Functional Human Dendritic Cells From Adherent Peripheral Blood Monocytes by CD40 Ligation in the Absence of Granulocyte-Macrophage Colony-Stimulating Factor Blood, December 1, 1998; 92(11): 4238 - 4247. [Abstract] [Full Text] [PDF]

				D. Sidransky Nucleic Acid-Based Methods for the Detection of Cancer Science, November 7, 1997; 278(5340): 1054 - 1058. [Abstract] [Full Text]